Concepedia

Nashar Y Gabrail

NY

Statistics

Publications

1

Citations

58

H-Index

1

Active since

2016

Affiliations

Northwest Medical Specialties(Current)

Nashar Y Gabrail is an author at Northwest Medical Specialties.

Publications per year

2016–2016

1

Publications

1

A randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small-cell lung cancer

Edward B. Garon, Jeffrey D. Neidhart, Nashar Y Gabrail et al. · OncoTargets and Therapy · 2016 · 58 citations · Full text

1–1 of 1